These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16956816)

  • 21. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
    Khong T; Sharkey J; Spencer A
    Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
    Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
    Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
    Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl esters.
    Alhomsi K; Selig M; Sustic T; Katrangi E; Weissig V; Laposata M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):534-43. PubMed ID: 18215210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460.
    Shyu KG; Huang ST; Kuo HS; Cheng WP; Lin YL
    Acta Pharmacol Sin; 2007 Apr; 28(4):559-66. PubMed ID: 17376296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS
    Clin Cancer Res; 2007 Aug; 13(16):4750-8. PubMed ID: 17699852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides.
    Ma G; Khan SI; Benavides G; Schühly W; Fischer NH; Khan IA; Pasco DS
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):35-43. PubMed ID: 17149609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
    Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
    Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
    Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
    Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
    Zheng X; Abroun S; Otsuyama K; Asaoku H; Kawano MM
    Haematologica; 2006 Jul; 91(7):920-8. PubMed ID: 16818279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biology of plasma cells.
    Chen-Kiang S
    Best Pract Res Clin Haematol; 2005; 18(4):493-507. PubMed ID: 16026733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 multiple myeloma cells.
    Bae S; Jeong HJ; Cha HJ; Kim K; Choi YM; An IS; Koh HJ; Lim DJ; Lee SJ; An S
    Int J Mol Med; 2012 Nov; 30(5):1180-6. PubMed ID: 22941251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a human plasma cell line in vitro.
    Burk KH; Drewinko B; Turjillo JM; Ahearn MJ
    Cancer Res; 1978 Aug; 38(8):2508-13. PubMed ID: 566614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.